Chemoinformaics analysis of CAPROIC ACID METHYL ESTER
| Molecular Weight | 130.187 | nRot | 4 |
| Heavy Atom Molecular Weight | 116.075 | nRig | 1 |
| Exact Molecular Weight | 130.099 | nRing | 0 |
| Solubility: LogS | -2.035 | nHRing | 0 |
| Solubility: LogP | 2.371 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 23 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 22.6291 |
| nHD | 0 | BPOL | 16.6489 |
| QED | 0.428 |
| Synth | 1.51 |
| Natural Product Likeliness | 0.417 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.016 |
| Pgp-sub | 0.019 |
| HIA | 0.003 |
| CACO-2 | -4.321 |
| MDCK | 0.0000303 |
| BBB | 0.997 |
| PPB | 0.536705 |
| VDSS | 0.78 |
| FU | 0.563811 |
| CYP1A2-inh | 0.928 |
| CYP1A2-sub | 0.767 |
| CYP2c19-inh | 0.426 |
| CYP2c19-sub | 0.823 |
| CYP2c9-inh | 0.135 |
| CYP2c9-sub | 0.787 |
| CYP2d6-inh | 0.015 |
| CYP2d6-sub | 0.223 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.206 |
| CL | 9.673 |
| T12 | 0.85 |
| hERG | 0.029 |
| Ames | 0.012 |
| ROA | 0.061 |
| SkinSen | 0.646 |
| Carcinogencity | 0.253 |
| EI | 0.978 |
| Respiratory | 0.203 |
| NR-Aromatase | 0.012 |
| Antiviral | No |
| Prediction | 0.951564 |